Neuroscientists are inured to complexity, but many researchers believed that when we got down to the level of genes, analysis of brain function would become simpler. Perhaps the field's focus over the last decade on Mendelian disorders, i.e., disorders due to a single major genetic locus acting in dominant or recessive fashion such as Huntington's disease, created excessive optimism that genes relevant to behavior and its ills would be easy to find and would provide a simple key to nervous system function. It is now apparent to all that the dream of simplicity was no more than a dream. Even for single-gene disorders such as Huntington's disease, discovery of the previously unknown gene initially raises many more questions than it answers. Moreover, we now recognize that mutations that give rise to Mendelian disorders are relatively rare.
Almost all interesting variations in behavior, including the mental illnesses such as depression, anxiety disorders, schizophrenia, and autism, have proven to be genetically complex. Unlike Mendelian disorders where a single gene has all the say, complex disorders result from the interaction of multiple genes and nongenetic factors. Rare Mendelian forms of schizophrenia or autism may exist, but if so they remain to be discovered. All our current information suggests that in the general population, vulnerability to mental illnesses-and, indeed, genetic contributions to the panoply of nonpathological behavioral phenotypes-is complex. In such situations, each genetic locus contributes only a small share of risk, and perhaps no single constellation of genes is required. In addition, because some gene-gene interactions are not additive (epistasis), some relevant alleles (sequence variants of a gene) may not contribute anything to risk in the absence of other alleles at other genetic loci. In short, the search for genes involved in behavioral variation or in risk for mental illness is beginning to feel like looking for needles in a haystack.
Despite these difficulties, the search for such genes remains a critical goal for the early years of this new millennium (we really needed a millennium of the brain, not a mere decade). Even if no single gene proves to be the key that unlocks the secrets underpinning a particular behavior or mental disorder, the isolation of genes remains critically important to both basic and clinical neuroscience. In the end, genes that are related to significant behavioral phenotypes should provide powerful bottom-up tools to investigate brain function. With such genes in hand we will be able to ask at what time during brain development a disease vulnerability gene is expressed, in what cells and circuits, and in what circumstances. This information may help epidemiologists narrow their search for environmental contributors to risk. We will also be able to use genetic manipulation of model organisms and neurobiological approaches to ask how a version of a gene that confers risk of illness differs in its functional effects from another version that does not. Genes, as the blueprints of cells, will also identify cellular pathways for the development of treatments for mental illness.
When it comes to behavior, genes are not fate; even in severe mental illnesses nongenetic factors play a role in every condition that has been studied. At the same time, however, genes cannot be ignored, for despite the complexity, genes, in aggregate, have a great deal to say about risk for many mental disorders. The impact of both genes and environment is illustrated by the severe, chronic mental disorder, schizophrenia. If, within a pair of monozygotic twins (twins sharing 100% of their DNA), one co-twin has schizophrenia, the other member of the twin pair has a 50% risk of developing it as well. This is a 50-fold elevation in risk above the general population rates; yet the risk is not 100%, evidence once again that while genes have much to say, they are not everything.
Modifier genes are a type of gene that may affect penetrance or expressivity, but that do not directly
